Location History:
- Indianapolis, IN (US) (2016)
- Indianapaolis, IN (US) (2019)
Company Filing History:
Years Active: 2016-2019
Title: Yulia Azriel: Innovator in Insulin Analog Research
Introduction
Yulia Azriel is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of insulin analogs, focusing on enhancing their potency and specificity for the insulin receptor. With a total of 2 patents, her work is paving the way for advancements in diabetes treatment.
Latest Patents
Yulia's latest patents include innovative single-chain insulin agonists that exhibit high activity at the insulin receptor. These single-chain insulin analogs are designed with optimally sized linking moieties to connect human insulin A and B chains, or their analogs and derivatives. One embodiment of her invention utilizes a polyethylene glycol linking moiety consisting of 6-16 monomer units. Another embodiment features a non-native amino acid sequence derived from the IGF-1 C-peptide, comprising at least 8 and no more than 12 amino acids in length. Additionally, her patents disclose prodrug and conjugate derivatives of these single-chain insulin analogs.
Career Highlights
Yulia Azriel is affiliated with Indiana University, where she continues her research and development in the field of insulin analogs. Her work is characterized by a commitment to improving the efficacy of diabetes treatments through innovative scientific approaches.
Collaborations
Yulia has collaborated with notable colleagues, including Richard Dennis DiMarchi and Zachary Kaur. These partnerships have further enriched her research and contributed to the advancement of her patented technologies.
Conclusion
Yulia Azriel's contributions to the field of insulin analogs are noteworthy and impactful. Her innovative patents and collaborations highlight her dedication to improving diabetes treatment options.